AGP Executive Report
Last update: 4 minutes agoHealth Tech & Care Access: A German study in Clinical Cardiology found that combining an EMLA numbing patch with lidocaine infiltration significantly cuts pain during and after transradial coronary angiography, with the lowest scores in the combo group. Medical Innovation Funding: Hanover-based Allogenetics raised €3.8m pre-Series A to advance its one-time ex vivo gene therapy (ALG-115) toward first-in-human lung transplant trials in late 2027/early 2028. Workforce & Policy Pressure: Germany’s far-right AfD’s record win in Saxony-Anhalt is driving fresh political heat, with implications for national policy direction that could spill into health and social priorities. Public Health Risk: Reports highlight Europe’s extreme heat as a growing health crisis, with Germany recording 16,300 heat-related deaths. Clinical Research & Devices: Market coverage points to continued growth in regenerative medicine, cancer vaccines, compression therapy, and intraocular lenses—reflecting demand from aging populations and chronic disease burdens.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
